Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Chappell

Showing results (221-230 of 247) with videos related to

Pageof 25
Sort By:
MMWR. Morbidity and Mortality Weekly Report|October 20, 2022
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022Diya Surie, Levi Bonnell, Katherine Adams, et al.
MMWR. Morbidity and Mortality Weekly Report|October 5, 2023
Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years - IVY Network, 20 U.S. States, February 2022-May 2023Diya Surie, Katharine A Yuengling, Jennifer DeCuir, et al.
MMWR. Morbidity and Mortality Weekly Report|February 27, 2025
Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025Ruth Link-Gelles, Sean Chickery, Alexander Webber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2024
Benefit of early oseltamivir therapy for adults hospitalized with influenza A: an observational studyNathaniel M Lewis, Elizabeth J Harker, Lauren B Grant, et al.
JAMA Network Open|April 4, 2024
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US AdultsDiya Surie, Katharine A Yuengling, Jennifer DeCuir, et al.
Vaccine|November 14, 2022
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United StatesCaitlin Turbyfill, Katherine Adams, Mark W Tenforde, et al.
The Journal of Infectious Diseases|April 6, 2022
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant RecipientsJennie H Kwon, Mark W Tenforde, Manjusha Gaglani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 6, 2024
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024Kevin C Ma, Diya Surie, Adam S Lauring, et al.
Open Forum Infectious Diseases|January 25, 2023
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022Nathaniel M Lewis, Nancy Murray, Katherine Adams, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2022
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United StatesMark W Tenforde, Wesley H Self, Yuwei Zhu, et al.
Pageof 25

Showing results (221-230 of 247) with videos related to

Sort By:
Pageof 25
MMWR. Morbidity and Mortality Weekly Report|October 20, 2022
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022Diya Surie, Levi Bonnell, Katherine Adams, et al.
MMWR. Morbidity and Mortality Weekly Report|October 5, 2023
Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years - IVY Network, 20 U.S. States, February 2022-May 2023Diya Surie, Katharine A Yuengling, Jennifer DeCuir, et al.
MMWR. Morbidity and Mortality Weekly Report|February 27, 2025
Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025Ruth Link-Gelles, Sean Chickery, Alexander Webber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2024
Benefit of early oseltamivir therapy for adults hospitalized with influenza A: an observational studyNathaniel M Lewis, Elizabeth J Harker, Lauren B Grant, et al.
JAMA Network Open|April 4, 2024
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US AdultsDiya Surie, Katharine A Yuengling, Jennifer DeCuir, et al.
Vaccine|November 14, 2022
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United StatesCaitlin Turbyfill, Katherine Adams, Mark W Tenforde, et al.
The Journal of Infectious Diseases|April 6, 2022
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant RecipientsJennie H Kwon, Mark W Tenforde, Manjusha Gaglani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 6, 2024
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024Kevin C Ma, Diya Surie, Adam S Lauring, et al.
Open Forum Infectious Diseases|January 25, 2023
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022Nathaniel M Lewis, Nancy Murray, Katherine Adams, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2022
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United StatesMark W Tenforde, Wesley H Self, Yuwei Zhu, et al.
Pageof 25